Michelle Lynn Ols

Title: Michelle Lynn Ols: Innovator in Biocircuit Systems

Introduction

Michelle Lynn Ols is a prominent inventor based in Northborough, MA (US). She has made significant contributions to the field of biocircuit systems, holding 4 patents that focus on innovative therapeutic modalities. Her work is instrumental in advancing the understanding and application of protein expression systems.

Latest Patents

Ols' latest patents include "Membrane bound IL12 compositions and methods for tunable regulation." This patent provides regulatable biocircuit systems that offer modular and tunable protein expression systems, supporting the discovery and development of therapeutic modalities. Another notable patent is "CA2 compositions and methods for tunable regulation," which presents drug-responsive domains derived from human carbonic anhydrase 2. These domains can modulate protein stability for human interleukin 15 (IL15) payloads, along with compositions and methods of use.

Career Highlights

Michelle Lynn Ols is currently associated with Obsidian Therapeutics, Inc., where she continues to push the boundaries of innovation in her field. Her expertise and dedication have positioned her as a key player in the development of advanced therapeutic solutions.

Collaborations

Ols collaborates with talented individuals such as Dhruv Kam Sethi and Dexue Sun, contributing to a dynamic and innovative work environment.

Conclusion

Michelle Lynn Ols exemplifies the spirit of innovation in the biotechnology sector. Her patents and ongoing work at Obsidian Therapeutics, Inc. highlight her commitment to advancing therapeutic modalities through cutting-edge research.